Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma

被引:102
作者
Edakuni, G
Sasatomi, E
Satoh, T
Tokunaga, O
Miyazaki, K
机构
[1] Saga Med Sch, Dept Pathol, Saga, Japan
[2] Saga Med Sch, Dept Surg, Saga, Japan
关键词
breast carcinoma; c-Met; cancer front; hepatocyte growth factor; Ki-67 labeling index;
D O I
10.1046/j.1440-1827.2001.01182.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Expression of hepatocyte growth factor (HGF) and c-Met (HGF receptor) has been reported in many neoplasms. We investigated coexpression of HGF and c-Met to determine the role of the HGF/c-Met pathway in breast carcinoma, especially at the cancer front. Eighty-eight cases of carcinoma of the breast were studied by immunohistochemistry and by in situ hybridization for HGF and c-Met expression. The staining pattern was termed 'front accentuation pattern' when it was most conspicuous at the cancer front. HGF and c-Met proteins were expressed in cancer and stromal cells, with autocrine and paracrine patterns. The front accentuation pattern of c-Met was observed in cancer cells, but not in stromal cells. The front accentuation pattern was not observed in HGF. Coexpression of HGF and c-Met at the cancer front was correlated with histologic grade, reduced patient survival and a high Ki-67 labeling index. Our findings suggest that the HGF/c-Met pathway acts primarily as a mitogen, especially at the cancer front, in a paracrine manner and affects some clinical factors, including patient survival.
引用
收藏
页码:172 / 178
页数:7
相关论文
共 36 条
  • [1] Beviglia L, 1997, INT J CANCER, V74, P301, DOI 10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO
  • [2] 2-E
  • [3] IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT
    BOTTARO, DP
    RUBIN, JS
    FALETTO, DL
    CHAN, AML
    KMIECIK, TE
    VANDEWOUDE, GF
    AARONSON, SA
    [J]. SCIENCE, 1991, 251 (4995) : 802 - 804
  • [4] HEPATOCYTE GROWTH-FACTOR SCATTER FACTOR INDUCES A VARIETY OF TISSUE-SPECIFIC MORPHOGENIC PROGRAMS IN EPITHELIAL-CELLS
    BRINKMANN, V
    FOROUTAN, H
    SACHS, M
    WEIDNER, KM
    BIRCHMEIER, W
    [J]. JOURNAL OF CELL BIOLOGY, 1995, 131 (06) : 1573 - 1586
  • [5] HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH
    BUSSOLINO, F
    DIRENZO, MF
    ZICHE, M
    BOCCHIETTO, E
    OLIVERO, M
    NALDINI, L
    GAUDINO, G
    TAMAGNONE, L
    COFFER, A
    COMOGLIO, PM
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 119 (03) : 629 - 641
  • [6] Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases
    Fujita, S
    Sugano, K
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (06) : 378 - 383
  • [7] Gerdes J, 1984, Hematol Oncol, V2, P365
  • [8] Ghoussoub RAD, 1998, CANCER, V82, P1513, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO
  • [9] 2-7
  • [10] Jin L, 1997, CANCER, V79, P749, DOI 10.1002/(SICI)1097-0142(19970215)79:4<749::AID-CNCR12>3.0.CO